Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Centocor ( CNTO ) -- Ignore unavailable to you. Want to Upgrade?

To: thebeach who wrote (775)	8/25/1998 1:49:00 PM
From: Hong-Lee Yu	Respond to of 965

Well, I am not sure about the short-term. CNTO has been up 15% over last week. so a little profit taking is expected. To value the company, you'll have to use year 2000 earning as a basis. EPS for year 2000 ranges from 2.0 to 3.5. There are numerous upcoming events that will affect the price movements. It is very fun and exciting to own CNTO. Events include 1) IMNX Enbriel's FDA advisory meeting (September 3) 2) Quarterly report 3) Phase III results of Remicade for RA and NDA filing for RA (Nvember and end of year) 4) ReoPro+Retavase for AMI (phase III sometimes next year)